Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The price of Zhengye Biotechnology Holding Ltd (NASDAQ: ZYBT) closed at $9.02 in the last session, up 10.27% from day before closing price of $8.18. In other words, the price has increased by $10.27 from its previous closing price. On the day, 0.54 million shares were traded.
Ratios:
We take a closer look at ZYBT’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 365.35 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 65.97. For the most recent quarter (mrq), Quick Ratio is recorded 0.81 and its Current Ratio is at 1.34. In the meantime, Its Debt-to-Equity ratio is 0.31 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
As of this moment, Zhengye’s Price-to-Earnings (P/E) ratio for their current fiscal year is 151.60. For the stock, the TTM Price-to-Sale (P/S) ratio is 16.28 while its Price-to-Book (P/B) ratio in mrq is 10.98.
Stock Price History:
Over the past 52 weeks, ZYBT has reached a high of $14.30, while it has fallen to a 52-week low of $3.50. The 50-Day Moving Average of the stock is 13.72%, while the 200-Day Moving Average is calculated to be 45.09%.
Shares Statistics:
A total of 47.17M shares are outstanding, with a floating share count of 4.43M. Insiders hold about 90.66% of the company’s shares, while institutions hold 0.00% stake in the company.
